Sona Nanotech Inc. operates as a nanotechnology life sciences company in the United States and Canada The company researchers and develops gold nanoparticles for potential therapies, including photothermal therapy, tumor targeting activity, anti-bacterial activity, and drug delivery vehicle, as well as diagnostics, such as diagnostic markers for imaging and immunoassay and biosensing. It also engages in the development of targeted hyperthermia therapy, a photo thermal therapy for the treatment of cancer tumors; and diagnostic tools comprising lateral flow assay rapid and bovine tuberculosis tests. The company was founded in 2013 and is based in Halifax, Canada.
Metrics to compare | SONA | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSONAPeersSector | |
|---|---|---|---|---|
P/E Ratio | −11.5x | −1.4x | −0.4x | |
PEG Ratio | −2.95 | 0.00 | 0.00 | |
Price/Book | −211.5x | 1.3x | 2.6x | |
Price / LTM Sales | - | 1.3x | 3.2x | |
Upside (Analyst Target) | 366.7% | 108.0% | 45.4% | |
Fair Value Upside | Unlock | 23.2% | 7.0% | Unlock |